PICK1调控TLR4/MyD88/ERK通路在炎症诱导胶质瘤发生发展中的作用机制
批准号:
81772664
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
王震
依托单位:
学科分类:
肿瘤发生
结题年份:
2021
批准年份:
2017
项目状态:
已结题
项目参与者:
郝珂、刘欣、马英玉、麻育源、洪胜辉、李凯强、陈娟、郑宇、吴妍
中文摘要
胶质瘤是最常见神经系统恶性肿瘤,有研究表明胶质瘤的发生发展与炎症相关,通过胶质瘤中Toll样受体4(TLR4)激活NF-κB,而促进胶质瘤的发展,但具体机制尚不明确。我们在研究PICK1与受体运输中发现胶质瘤中PICK1表达量明显降低,在恢复PICK1表达后,胶质瘤细胞表面TLR4数量明显下调,细胞增殖受抑;同时胶质细胞研究表明TLR4主要通过MEK/ERK通路调控炎症因子表达;小鼠胶质瘤模型也已证实在PICK1敲除小鼠中成瘤率明显增加。据此我们提出假设,胶质瘤细胞中PICK1通过与TLR4结合影响TLR4的运输,从而调控TLR4/MyD88/ERK信号通路影响胶质瘤的发生发展。本项目拟通过PICK1条件敲除等小鼠制备癌基因激活胶质瘤模型,结合分子、细胞和组织等层次对PICK1与TLR4的作用机制,及调控TLR4/MyD88通路影响胶质瘤发生发展的具体机制,为胶质瘤的防治提供理论依据。
英文摘要
Glioma is the most common neurological malignancy. Studies have shown that the occurrence and development of glioma is related to inflammation. The development of glioma may be induced by the activation of NF-κB through the Toll-like receptor 4 (TLR4), while the specific mechanism is not clear. In our group, we have studied the protein interacting with C-kinase 1 (PICK1) and receptor transport, and we found that the expression of PICK1 in glioma cells was significantly decreased. After restoring the expression of PICK1, the number of TLR4 in the membrane of glioma cells was down-regulated and the cell proliferation was inhibited. The researches on glial cells have shown that TLR4 regulates the expression of inflammatory factor mainly through the MEK / ERK pathway. The PICK1 knockout mice showed higher rate of tumor formation than control model. Based on these results, we hypothesize that the PICK1 participate in the transport of TLR4 by binding to TLR4 in glioma cells, and then regulate the expression of TLR4 / MyD88 /ERK signaling pathway to affect the development of glioma. This proposal aims to study the specific mechanism of PICK1-TLR4 interaction, and TLR4/MyD88 pathway in the occurrence and development of glioma, by setting up an oncogene-activated mouse glioma model with knockout of PICK1. The study will also focus on the aspects of molecule, cell, and tissue, and will provide a theoretical basis for the prevention and treatment of glioma.
胶质瘤是最常见神经系统恶性肿瘤,有研究表明胶质瘤的发生发展与炎症相关,通过胶质瘤中Toll样受体4(TLR4),而促进胶质瘤的发展,但具体机制尚不明确。我们在PICK1介导的肿瘤发展机制研究发现:PICK1是肿瘤EMT进程的重要分子标志物,与经典EMT相关分子具有联合诊断意义;PICK1/TLR4在胶质瘤发生发展中的协同,PICK1能够与TLR4结合介导TLR4上下膜,影响TLR4/MYD88/ERK炎症信号通路。在了解PICK1在胶质瘤作用的基础上,我们构建了PICK1分子多肽,连接特异性穿膜肽后,利用分子生物学技术在分子、细胞和形态等层次治疗胶质瘤,为胶质瘤的防治提供理论依据。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
A novel absorption spectrometric method, based on graphene nanomaterials, for detection of hepatocellular carcinoma-specific T lymphocyte cells.
基于石墨烯纳米材料的新型吸收光谱法检测肝细胞癌特异性T淋巴细胞
DOI:
10.2147/ijn.s168574
发表时间:
2018
期刊:
International journal of nanomedicine
影响因子:
8
作者:
[Zhu J, Li Y, Li L, Wang J, Wang H, Hong W, Hao K, Xue Y, Chen B, Wang Z]
通讯作者:
Wang Z
Protection of plasma transfusion against lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure through inhibiting apoptosis of hepatic cells in mice
通过抑制肝细胞凋亡保护血浆输注免受脂多糖/d-半乳糖胺诱导的暴发性肝衰竭
DOI:
10.1631/jzus.b1700277
发表时间:
2018-06-01
期刊:
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B
影响因子:
5.1
作者:
[Chen, Bing-yu, Jiang, Lu-xi, Wang, Zhen]
通讯作者:
Wang, Zhen
Islet-cell autoantigen 69 accelerates liver regeneration by downregulating Tgfbr1 and attenuating Tgfβ signaling in mice
胰岛细胞自身抗原 69 通过下调 Tgfbr1 和减弱小鼠 Tgf beta 信号传导加速肝脏再生
DOI:
10.1002/1873-3468.13859
发表时间:
2020-07-17
期刊:
FEBS LETTERS
影响因子:
3.5
作者:
[Chen, Linjie, Tao, Fei, Lyu, Jianxin]
通讯作者:
Lyu, Jianxin
C21 Fraction Refined from Marsdenia tenacissima-Induced Apoptosis is Enhanced by Suppression of Autophagy in Human Gastric Cell Lines.
从 Marsdenia tenacissima 精制的 C21 组分通过抑制人胃细胞系中的自噬而增强诱导的细胞凋亡
DOI:
10.1021/acsomega.0c02748
发表时间:
2020-10-06
期刊:
ACS omega
影响因子:
4.1
作者:
[Li K, Hao K, Zhang Y, Xu A, Wang Q, Du Y, Wu L, Chen B, Zhang W, Wang Z]
通讯作者:
Wang Z
Non-RBM Mutations Impaired SARS-CoV-2 Spike Protein Regulated to the ACE2 Receptor Based on Molecular Dynamic Simulation.
基于分子动力学模拟的非 RBM 突变损害了 ACE2 受体调节的 SARS-CoV-2 刺突蛋白
DOI:
10.3389/fmolb.2021.614443
发表时间:
2021
期刊:
Frontiers in molecular biosciences
影响因子:
5
作者:
[Du Y, Wang H, Chen L, Fang Q, Zhang B, Jiang L, Wu Z, Yang Y, Zhou Y, Chen B, Lyu J, Wang Z]
通讯作者:
Wang Z
共 9 条
基于多组学研究的PICK1少弱精子症机制及分子标志物联合检测方法评估
-
批准号:82172363
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:王震
-
依托单位:
PICK1基因突变致癫痫的发病机制及其分子诊断方法研究
-
批准号:81501824
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2015
-
负责人:王震
-
依托单位:
国内基金
海外基金